v3.25.3
Condensed Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2023 $ 319,000 $ 112,947,107 $ (100,160,891) $ 13,105,216
Balance (in Shares) at Dec. 31, 2023 106,333 115      
Stock-based compensation expense 1,235,207 1,235,207
Cancellation of common stock
Cancellation of common stock (in Shares) (1)      
Issuance of restricted stock 5,775 5,775
Issuance of restricted stock (in Shares) 3      
Common stock withheld to pay taxes (4,235) (4,235)
Common stock withheld to pay taxes (in Shares) (1)      
Sale of common stock, warrants and pre-funded warrants pursuant to a registration statement on Form S-1 4,492,198 4,492,198
Sale of common stock, warrants and pre-funded warrants pursuant to a registration statement on Form S-1 (in Shares) 78      
Fees incurred in connection with equity offerings (960,700) (960,700)
Warrants exercised for common stock 8,220 8,220
Warrants exercised for common stock (in Shares) 439      
Series C preferred stock dividends (225,000) (225,000)
Net loss (5,302,205) (5,302,205)
Balance at Sep. 30, 2024 $ 319,000 117,498,572 (105,463,096) 12,354,476
Balance (in Shares) at Sep. 30, 2024 106,333 633      
Balance at Jun. 30, 2024 $ 319,000 113,589,788 (103,944,291) 9,964,497
Balance (in Shares) at Jun. 30, 2024 106,333 117      
Stock-based compensation expense 411,895 411,895
Cancellation of common stock
Cancellation of common stock (in Shares) (1)      
Sale of common stock, warrants and pre-funded warrants pursuant to a registration statement on Form S-1 4,492,198 4,492,198
Sale of common stock, warrants and pre-funded warrants pursuant to a registration statement on Form S-1 (in Shares) 78      
Fees incurred in connection with equity offerings (928,529) (928,529)
Warrants exercised for common stock 8,220 8,220
Warrants exercised for common stock (in Shares) 439      
Series C preferred stock dividends (75,000) (75,000)
Net loss (1,518,805) (1,518,805)
Balance at Sep. 30, 2024 $ 319,000 117,498,572 (105,463,096) 12,354,476
Balance (in Shares) at Sep. 30, 2024 106,333 633      
Balance at Dec. 31, 2024 $ 791,245 118,758,596 (109,164,636) 10,385,205
Balance (in Shares) at Dec. 31, 2024 106,953 3,198      
Stock-based compensation expense 956,279 956,279
Issuance of restricted stock 17,522 17,522
Issuance of restricted stock (in Shares) 250      
Sale of common stock, warrants and pre-funded warrants pursuant to a registration statement on Form S-1 14,377,835 14,377,835
Sale of common stock, warrants and pre-funded warrants pursuant to a registration statement on Form S-1 (in Shares) 3,013      
Fees incurred in connection with equity offerings (1,830,459) (1,830,459)
Warrants exercised for common stock $ 3 22,144 22,147
Warrants exercised for common stock (in Shares) 29,529      
Warrants exercised for common stock on a cashless basis $ 74 (74)
Warrants exercised for common stock on a cashless basis (in Shares) 732,202      
Conversion of Series H preferred stock for common stock $ (472,245) 472,245
Conversion of Series H preferred stock for common stock (in Shares) (310) 215      
Redemption of Series I preferred stock
Redemption of Series I preferred stock (in Shares) (310)      
Series C preferred stock dividends (225,000) (225,000)
Net loss (5,869,163) (5,869,163)
Balance at Sep. 30, 2025 $ 319,000 $ 77 132,549,088 (115,033,799) 17,834,366
Balance (in Shares) at Sep. 30, 2025 106,333 768,407      
Balance at Jun. 30, 2025 $ 319,000 $ 77 132,485,312 (113,408,294) 19,396,095
Balance (in Shares) at Jun. 30, 2025 106,333 768,407      
Stock-based compensation expense 138,776 138,776
Fees incurred in connection with equity offerings
Series C preferred stock dividends (75,000) (75,000)
Net loss (1,625,505) (1,625,505)
Balance at Sep. 30, 2025 $ 319,000 $ 77 $ 132,549,088 $ (115,033,799) $ 17,834,366
Balance (in Shares) at Sep. 30, 2025 106,333 768,407